Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Telomere Shortening By Terc Knockout in the Eµ-TCL1 Transgenic Murine Model of CLL: Characterization of Disease Development and Survival

Billy Michael Chelliah Jebaraj, PhD, Annika Scheffold, PhD, André Lechel, Sarah-Fee Katz, PhD, Eugen Tausch, Johannes Bloehdorn, MD, Daniela Steinbrecher, PhD, Vanni Torresi, Christof Schneider, MD, Hartmut Döhner, MD, Daniel Mertens, PhD, Lenhard Rudolph, Stephan Stilgenbauer

Blood (2019) 134 (Supplement_1): 1732.

https://doi.org/10.1182/blood-2019-126878

Published: 2019

Journal Articles

PI3Kδ Inhibition Elicits Anti-Leukemic Effects through Bim-Dependent Apoptosis

Matthew J Carter, PhD, Kerry L Cox, Stuart J Blakemore, Anna H Turaj, MSc, Robert J Oldham, Lekh N. Dahal, PhD, Stacey Tannheimer, Francesco Forconi, MD DM, PhD FRCPath, Graham Packham, PhD, Mark S Cragg, PhD

Blood (2016) 128 (22): 3241.

https://doi.org/10.1182/blood.V128.22.3241.3241

Published: 2016

Journal Articles

Mutational Status of Splenic Diffuse Red Pulp Small B-Cell Lymphoma Revealed By Whole Exome Sequencing

Nerea Martinez, Carmen Almaraz, Manuela Mollejo, Yolanda Campos-Martin, Sophia Derdak, Laura Cereceda, Alexandra Traverse-Glehen, Aurelie Verney, Lucile Baseggio, Fanny Camacho, Jose Pedro Vaque, Sergi Beltran, Ivo Gut, Miguel Angel A. Piris

Blood (2015) 126 (23): 1448.

https://doi.org/10.1182/blood.V126.23.1448.1448

Published: 2015

Journal Articles

Myeloproliferative Disease and Myeloid Leukemia in Dnmt3a Haploinsufficient Mice

Christopher B Cole, Angela M. Verdoni, PhD, Gue Su Chang, PhD, Chris Miller, PhD, Timothy J. Ley, MD

Blood (2014) 124 (21): 890.

https://doi.org/10.1182/blood.V124.21.890.890

Published: 2014

Journal Articles

Mutational Status of Splenic Marginal Zone Lymphoma Revealed by Whole Exome Sequencing.

Nerea Martinez, Ignacio Varela, Jose P. Vaque, Sophia Derdak, Sergi Beltran, Manuela Mollejo, Margarita Sanchez-Beato, Laura Cereceda, Monica Bayes, Marta Gut, David Oscier, Jose L. Rodriguez-Peralto, Francesc Sole, Maximo Fraga, Juan F. Garcia, Elena Sebastian, Ivo G. Gut, Miguel A. Piris

Blood (2012) 120 (21): 2698.

https://doi.org/10.1182/blood.V120.21.2698.2698

Published: 2012

Journal Articles

Vaccination with ΔCD40L or Flagellin Gene-Modified T Cells Activates Dendritic Cells In Vivo and Induces a Potent Anti-Tumor Immune Response

Adham S Bear, Meghan M Turnis, PhD, Xiao-Tong Song, PhD, Russell Cruz, MD, An Lu, Stephen Gottschalk, MD, Cliona M Rooney, PhD, Aaron E Foster, PhD

Blood (2011) 118 (21): 1909.

https://doi.org/10.1182/blood.V118.21.1909.1909

Published: 2011

Journal Articles

B Cell Depletion Reduces the Number and Function of T- Regulatory Cells and Enhances the Anti Tumor response

Tamar Tadmor, MD, Yu Zhang, MD, Robert Dunn, PHD, Seung-uon Shin, Hyung-Mee Cho, Joseph Rosenblatt, MD

Blood (2009) 114 (22): 3668.

https://doi.org/10.1182/blood.V114.22.3668.3668

Published: 2009

Journal Articles

EBV-Associated Follicular Dendritic Cell Tumor of the Spleen.

M. Houman Fekrazad, MD, Lizabeth Rosenbaum, M.D., Mohammad A. Vasef, M.D., Ian Rabinowitz, M.D.

Blood (2007) 110 (11): 4509.

https://doi.org/10.1182/blood.V110.11.4509.4509

Published: 2007

Journal Articles

TG101209, a Selective JAK2 Kinase Inhibitor, Suppresses Endogenous and Cytokine-Supported Colony Formation from Hematopoietic Progenitors Carrying JAK2 V617F or MPL W515K/L Mutations.

Animesh Pardanani, MD, PhD, John Hood, PhD, Terra Lasho, Glenn Noronha, PhD, Christy Finke, Chi Ching Mak, PhD, Ruben Mesa, MD, Hong Zhu, PhD, Richard Soll, PhD, Ayalew Tefferi, MD

Blood (2006) 108 (11): 2680.

https://doi.org/10.1182/blood.V108.11.2680.2680

Published: 2006

Journal Articles

Littoral Cell Hemangioma of the Spleen.

Seema Naik, MD, Farida Chaudhri, MD, Stephen Yang, MD

Blood (2005) 106 (11): 3953.

https://doi.org/10.1182/blood.V106.11.3953.3953

Published: 2005

Journal Articles

V H gene analysis of splenic marginal zone lymphomas reveals diversity in mutational status and initiation of somatic mutation in vivo

Delin Zhu, Jennifer Orchard, David G. Oscier, Dennis H. Wright, Freda K. Stevenson

Blood (2002) 100 (7): 2659–2661.

https://doi.org/10.1182/blood-2002-01-0169

Published: 2002

NARROW

Telomere Shortening By Terc Knockout in the Eµ-TCL1 Transgenic Murine Model of CLL: Characterization of Disease Development and Survival

PI3Kδ Inhibition Elicits Anti-Leukemic Effects through Bim-Dependent Apoptosis

Mutational Status of Splenic Diffuse Red Pulp Small B-Cell Lymphoma Revealed By Whole Exome Sequencing

Myeloproliferative Disease and Myeloid Leukemia in Dnmt3a Haploinsufficient Mice

Mutational Status of Splenic Marginal Zone Lymphoma Revealed by Whole Exome Sequencing.

Vaccination with ΔCD40L or Flagellin Gene-Modified T Cells Activates Dendritic Cells In Vivo and Induces a Potent Anti-Tumor Immune Response

B Cell Depletion Reduces the Number and Function of T- Regulatory Cells and Enhances the Anti Tumor response

EBV-Associated Follicular Dendritic Cell Tumor of the Spleen.

TG101209, a Selective JAK2 Kinase Inhibitor, Suppresses Endogenous and Cytokine-Supported Colony Formation from Hematopoietic Progenitors Carrying JAK2 V617F or MPL W515K/L Mutations.

Littoral Cell Hemangioma of the Spleen.

V H gene analysis of splenic marginal zone lymphomas reveals diversity in mutational status and initiation of somatic mutation in vivo

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only